Full Text View
Tabular View
No Study Results Posted
Related Studies
Monoclonal Antibody Therapy and Docetaxel in Treating Women With Metastatic or Recurrent Breast Cancer
This study is ongoing, but not recruiting participants.
Study NCT00028483   Information provided by National Cancer Institute (NCI)
First Received: January 4, 2002   Last Updated: May 30, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Breast Cancer
Additional conditions recognized in this trial
Breast Neoplasms
More general conditions related to this trial
Breast Diseases
Neoplasms
Neoplasms by Site
Skin Diseases
Interventions listed in this trial
cBR96-doxorubicin immunoconjugate
docetaxel
Additional drug interventions recognized in this trial
Antibodies, Monoclonal
Doxorubicin
Immunoconjugates
More general drug interventions related to this trial
Antibiotics, Antineoplastic
Antineoplastic Agents
Immunologic Factors
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
Seattle Genetics, Inc.


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services